Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Rabin Medical Center.
Recruitment status was  Recruiting
Study NCT01146288   Information provided by Rabin Medical Center

First Received on June 16, 2010.   Last Updated on August 3, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity-induced Hyperfiltration
Additional conditions recognized in this trial
Obesity
More general conditions related to this trial
Body Weight
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
furosemide, acetazolamide
Additional drug interventions recognized in this trial
Acetazolamide
Furosemide
More general drug interventions related to this trial
Anticonvulsants
Carbonic Anhydrase Inhibitors
Cardiovascular Agents
Central Nervous System Agents
Diuretics
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Rabin Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services